Anlikang: Obtains Etoricoxib Tablets Drug Registration Certificate
Angelikang Pharmaceutical has received approval from China's National Medical Products Administration for its etoricoxib tablet, a medication used to treat inflammatory conditions like osteoarthritis and gout. This approval marks a significant step for the company in the pharmaceutical market. The drug is indicated for symptomatic relief of acute and chronic inflammatory conditions, as well as acute gouty arthritis and primary dysmenorrhea. AI